---
title: "Zhejiang Hisoar Pharmaceutical Co., Ltd. Announces Board Appointments"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/266617933.md"
description: "Zhejiang Hisoar Pharmaceutical Co., Ltd. held its 1st Extraordinary General Meeting of 2025 on 18 November 2025, approved the appointment of Chen Guangshun, non-independent director, Chen Fangqi, non-independent director."
datetime: "2025-11-19T21:11:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266617933.md)
  - [en](https://longbridge.com/en/news/266617933.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266617933.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/266617933.md) | [繁體中文](https://longbridge.com/zh-HK/news/266617933.md)


# Zhejiang Hisoar Pharmaceutical Co., Ltd. Announces Board Appointments

Zhejiang Hisoar Pharmaceutical Co., Ltd. held its 1st Extraordinary General Meeting of 2025 on 18 November 2025, approved the appointment of Chen Guangshun, non-independent director, Chen Fangqi, non-independent director.

### 相关股票

- [HISOAR (002099.CN)](https://longbridge.com/zh-CN/quote/002099.CN.md)

## 相关资讯与研究

- [Stitt signs executive order declaring a state of emergency for NE OK](https://longbridge.com/zh-CN/news/278230168.md)
- [Mesa Laboratories Names New CEO for Next Phase](https://longbridge.com/zh-CN/news/278450802.md)
- [Santhera Pharma Appoints Marc Clausse As Chief Commercial Officer](https://longbridge.com/zh-CN/news/278499117.md)
- [<![CDATA[Vinay Prasad Out at CBER for Second Time in Under a Year]]>](https://longbridge.com/zh-CN/news/278405131.md)
- [BYD reportedly explores F1 entry to boost global brand appeal](https://longbridge.com/zh-CN/news/278576491.md)